A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures

被引:3
作者
Ryu, Hyejo [1 ,2 ]
Shin, Kyung Hwan [2 ,3 ,4 ]
Chang, Ji Hyun [2 ,3 ]
Jang, Bum-Sup [2 ,3 ]
机构
[1] Chung Ang Univ, Dept Radiat Oncol, Gwangmyeong Hosp, Gwangmyeong, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea
[4] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea
关键词
TARGET VOLUME DELINEATION; RADIATION-THERAPY; UK STANDARDIZATION; HYPOFRACTIONATION; OUTCOMES; IMPACT; TRIAL;
D O I
10.1038/s41416-024-02741-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We examined the patterns of breast reconstruction postmastectomy in breast cancer patients undergoing postmastectomy radiotherapy (PMRT) and compared complications based on radiotherapy fractionation and reconstruction procedures.Methods Using National Health Insurance Service (NHIS) data (2015-2020), we analysed 4669 breast cancer patients with PMRT and reconstruction. Using propensity matching, cohorts for hypofractionated fractionation (HF) and conventional fractionation (CF) were created, adjusting for relevant factors and identifying grade >= 3 complications.Result Of 4,669 patients, 30.6% underwent HF and 69.4% CF. The use of HF has increased from 19.4% in 2015 to 41.0% in 2020. Immediate autologous (32.9%) and delayed two-stage implant reconstruction (33.9%) were common. Complication rates for immediate (N = 1286) and delayed two-stage (N = 784) reconstruction were similar between HF and CF groups (5.1% vs. 5.4%, P = 0.803, and 10.5% vs. 10.7%, P = 0.856, respectively) with median follow-ups of 2.5 and 2.6 years. HF showed no increased risk of complications across reconstruction methods.Conclusion A nationwide cohort study revealed no significant difference in complication rates between the HF and CF groups, indicating HF for reconstructed breasts is comparable to CF. However, consultation regarding the fractionation for reconstructed breast cancer patients may still be necessary.
引用
收藏
页码:290 / 298
页数:9
相关论文
共 28 条
  • [1] Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)60348-7, 10.1016/S1470-2045(08)70077-9]
  • [2] Influence of Radiation Dose to Reconstructed Breast Following Mastectomy on Complication in Breast Cancer Patients Undergoing Two-Stage Prosthetic Breast Reconstruction
    Chang, Jee Suk
    Song, Seung Yong
    Oh, Joo Hyun
    Lew, Dae Hyun
    Roh, Tai Suk
    Kim, Se Young
    Keum, Ki Chang
    Lee, Dong Won
    Kim, Yong Bae
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] The effect of post mastectomy radiation therapy on breast reconstruction with and without acellular dermal matrix: a systematic review and meta-analysis protocol
    Chung, Amy M.
    Stein, Michael J.
    Ghumman, Ammara
    Zhang, Jing
    [J]. SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [4] Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study
    Chung, Seung Yeun
    Chang, Jee Suk
    Shin, Kyung Hwan
    Kim, Jin Ho
    Park, Won
    Kim, Haeyoung
    Kim, Kyubo
    Lee, Ik Jae
    Yoon, Won Sup
    Cha, Jihye
    Lee, Kyu-Chan
    Kim, Jin Hee
    Choi, Jin Hwa
    Ahn, Sung-Ja
    Ha, Boram
    Lee, Sun Young
    Lee, Dong Soo
    Lee, Jeongshim
    Shin, Sei One
    Lee, Sea-Won
    Choi, Jinhyun
    Kim, Mi Young
    Kim, Yeon Joo
    Im, Jung Ho
    Suh, Chang-Ok
    Kim, Yong Bae
    [J]. BREAST, 2021, 56 : 7 - 13
  • [5] Outcomes of Acellular Dermal Matrix for Immediate Tissue Expander Reconstruction with Radiotherapy: A Retrospective Cohort Study
    Craig, Elizabeth S.
    Clemens, Mark W.
    Koshy, John C.
    Wren, James
    Hong, Zhang
    Butler, Charles E.
    Garvey, Patrick B.
    Selber, Jesse C.
    Kronowitz, Steven J.
    [J]. AESTHETIC SURGERY JOURNAL, 2019, 39 (03) : 279 - 288
  • [6] The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
    Dahn, Hannah M.
    Boersma, Liesbeth J.
    de Ruysscher, Dirk
    Meattini, Icro
    Offersen, Birgitte, V
    Pignol, Jean-Philippe
    Aristei, Cynthia
    Belkacemi, Yazid
    Benjamin, Dori
    Bese, Nuran
    Coles, Charlotte E.
    Franco, Pierfrancesco
    Ho, Alice
    Hol, Sandra
    Jagsi, Reshma
    Kirby, Anna M.
    Marrazzo, Livia
    Marta, Gustavo N.
    Moran, Meena S.
    Nichol, Alan M.
    Nissen, Henrik D.
    Strnad, Vratislav
    Zissiadis, Yvonne E.
    Poortmans, Philip
    Kaidar-Person, Orit
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [7] Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
    de Siqueira, Gabriela S. M.
    Hanna, Samir A.
    de Moura, Larissa F.
    Miranda, Fabiana Accioli
    Carvalho, Heloisa de Andrade
    Marta, Gustavo Nader
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2022, 14
  • [8] Gradishar WJ, 2023, NCCN GUIDELINES VERS
  • [9] The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
    Haviland, Joanne S.
    Owen, J. Roger
    Dewar, John A.
    Agrawal, Rajiv K.
    Barrett, Jane
    Barrett-Lee, Peter J.
    Dobbs, H. Jane
    Hopwood, Penelope
    Lawton, Pat A.
    Magee, Brian J.
    Mills, Judith
    Simmons, Sandra
    Sydenham, Mark A.
    Venables, Karen
    Bliss, Judith M.
    Yarnold, John R.
    [J]. LANCET ONCOLOGY, 2013, 14 (11) : 1086 - 1094
  • [10] Ho AY, 2017, LANCET ONCOL, V18, pE742, DOI [10.1016/S1470-2045(17)30617-4, 10.1016/s1470-2045(17)30617-4]